Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:23 pm Purchase |
2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 987,211 9.990% |
987,211 (New Position) |
Filing History |
| 2023-02-14 12:22 pm Purchase |
2022-12-31 | 13G | ContraFect Corporation CFRX |
Armistice Capital, LLC | 60,358 9.990% |
60,358 (New Position) |
Filing History |
| 2023-02-14 12:20 pm Purchase |
2022-12-31 | 13G | Conformis, Inc. CFMS |
Armistice Capital, LLC | 480,000 6.000% |
480,000 (New Position) |
Filing History |
| 2023-02-14 12:19 pm Purchase |
2022-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ |
Armistice Capital, LLC | 2,666,666 6.750% |
2,666,666 (New Position) |
Filing History |
| 2023-02-14 12:18 pm Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Armistice Capital, LLC | 1,165,709 4.990% |
1,165,709 (New Position) |
Filing History |
| 2023-02-14 12:16 pm Sale |
2022-12-31 | 13G | Bit Digital, Inc. BTBT |
Armistice Capital, LLC | 3,161,889 3.690% |
-1,053,963 (-25.00%) |
Filing History |
| 2023-02-14 12:15 pm Purchase |
2022-12-31 | 13G | Bruush Oral Care Inc. BRSH |
Armistice Capital, LLC | 44,917 9.990% |
44,917 (New Position) |
Filing History |
| 2023-02-14 12:06 pm Purchase |
2022-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 955,995 9.990% |
23,943 (+2.57%) |
Filing History |
| 2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | Biora Therapeutics, Inc. BIOR |
Armistice Capital, LLC | 1,298,965 5.700% |
1,298,965 (New Position) |
Filing History |
| 2023-02-14 12:03 pm Purchase |
2022-12-31 | 13G | Avinger, Inc. AVGR |
Armistice Capital, LLC | 52,627 9.990% |
52,627 (New Position) |
Filing History |
| 2023-02-14 12:02 pm Purchase |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Armistice Capital, LLC | 10,224,000 5.910% |
10,224,000 (New Position) |
Filing History |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-14 11:59 am Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-14 11:58 am Purchase |
2022-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Armistice Capital, LLC | 5,333,951 9.990% |
5,333,951 (New Position) |
Filing History |
| 2023-02-14 11:54 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Armistice Capital, LLC | 2,750,000 5.010% |
2,750,000 (New Position) |
Filing History |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Addex Therapeutics Ltd ADXN |
Armistice Capital, LLC | 201,923 4.970% |
170,283 (+538.19%) |
Filing History |
| 2023-02-14 11:52 am Purchase |
2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 880,000 7.590% |
880,000 (New Position) |
Filing History |
| 2023-02-14 11:50 am Purchase |
2022-12-31 | 13G | Talphera, Inc. TLPH |
Armistice Capital, LLC | 864,328 9.990% |
864,328 (New Position) |
Filing History |
| 2023-02-14 11:49 am Purchase |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Armistice Capital, LLC | 1,106,000 6.440% |
1,106,000 (New Position) |
Filing History |
| 2023-02-10 4:28 pm Purchase |
2022-12-31 | 13G | Cyclo Therapeutics, Inc. CYTH |
Armistice Capital, LLC | 1,030,000 10.800% |
814,674 (+378.34%) |
Filing History |